Article thumbnail
Location of Repository

Effects on blood glucose, insulin, lipid and proatherosclerotic parameters in stable type 2 diabetic subjects during an oral fat challenge

By Chung-Jung Wu and Zer-Ran Yu

Abstract

BACKGROUND: Restriction of fat intake has been effective in improving insulin sensitivity in obese and type 2 diabetic subjects, but what effects the recommended diet (less than 30% of total calories from fat) have not been elucidated in subjects with type 2 diabetes. The purpose of this study was to test the effects of oral fat challenge, composing 30% calories of a meal, on blood glucose, insulin, lipid, leptin, plasminogen activator inhibitor-1 (PAI-1) and tumor necrosis factor-α (TNF-α). DESIGN AND METHODS: Blood glucose, insulin, lipid, leptin, TNF-α and PAI-1 were compared in 14 type 2 diabetic patients and 10 normal subjects after an oral fat challenge upto 2 hours (fasting, 15 min, 30 min, 45 min, 60 min, 90 min and 120 min). RESULTS: Postprandial glucose, total cholesterol, leptin, PAI-1 levels did not differ significantly from levels at fasting. Serum triglyceride increased significantly from baseline only in diabetic patients (P = 0.042). Serum insulin increased postprandially in both groups (P = 0.028 in diabetic group and P = 0.055 in normal group), with displaying a prolonged insulin response in diabetic subjects. TNF-α decreased postprandially in both groups without significant difference, although diabetic patients have higher baseline levels (P = 0.024 compared to normal subjects). CONCLUSIONS: Oral fat load does not have an acute effect on blood glucose, total cholesterol, leptin and PAI-1 levels in both type 2 diabetic and normal subjects. TNF-α value showed decreased trend in both diabetic and normal subjects. The tendency of a delayed postprandial insulin response and elevated serum triglyceride level in diabetic subjects might be related to insulin resistance at the level of adipose tissue. Additional research is needed to assess the impact of the use of fat contents on the macronutrient composition of the diet, and potentially healthy and nutritional benefits for patients with diabetes

Topics: Research
Publisher: BioMed Central
Year: 2004
DOI identifier: 10.1186/1476-511X-3-17
OAI identifier: oai:pubmedcentral.nih.gov:484204
Provided by: PubMed Central

Suggested articles

Citations

  1. (2002). ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time. Hypertension
  2. (2000). AJ: The importance of lipidderived malondialdehyde in diabetes mellitus. Diabetologia
  3. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
  4. (2002). DM: Diabetes Prevention Program Research Group. Reduction in the evidence of type 2 diabetes with lifestyle intervention or metformin.
  5. (1999). Eriksson P: Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells. Arterioscler Thromb Vasc Biol
  6. (2002). FB: Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care
  7. (2001). Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
  8. (1996). Giugliano D: Oxidative stress and insulin action. Is there a relationship? Diabetologia
  9. (1995). GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
  10. (1991). Havekes L: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb
  11. (1992). Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes
  12. (2002). JE: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA
  13. (2001). JL: Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes
  14. (1996). Loskutoff DJ: Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.
  15. (1992). Patsch W: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb
  16. (1998). Postprandial lipidemia and hemostatic factors. Atherosclerosis
  17. (1987). Reaven GM: Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in non-insulin-dependent diabetes mellitus.
  18. (2001). Tremoli E: Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes
  19. (1988). YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.